New study aims to reduce extra doctor visits during labor pain management
NCT ID NCT04728048
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at two ways to give pain relief during labor: a standard epidural and a newer technique called dural puncture epidural. The goal was to see which method required fewer extra visits from the doctor to adjust the pain medicine. 130 healthy pregnant women participated, and the results help doctors choose the best approach for managing labor pain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
130 people
The number who actually took part.
- Started
-
Jan 2021
- Finished
-
Sep 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Healthy pregnant women (ASA 1 and 2) requesting epidural analgesia during labour. 2. Primiparous and multiparous parturients at term gestation (37 to 42 weeks). 3. Women 18 years old and older. 4. Administration of epidural analgesia between 7am and 4pm on weekdays. 5. Singleton and vertex presentation foetus. 6. Cervical dilatation ≤ 5 cm. 7. BMI ≤ 40. 8. French speaking Exclusion Criteria: 1. Pregnancy diseases such as gestational hypertension, preeclampsia and gestational diabetes. 2. Contraindications to neuraxial analgesia: thrombocytopenia \< 70 x 109/L, spinal cord anomalies, anticoagulation therapy, etc. 3. Known important fetal anomalies. 4. Allergy to any of the medications used in the study. 5. Suspected chorioamnionitis with spontaneous premature rupture of membranes (PROM). 6. Difficulty understanding and speaking French.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anesthesia are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CIUSSS de l'Est de l'Île de Montréal
Montreal, Quebec, H1T2M4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Newer sedative faces off against propofol in heart patients
- Could a whiff of xenon replace the Pre-Surgery chill pill?
- Can a gentler anesthesia cocktail protect a child's developing brain?
- Can a warm wet towel take the edge off labor pain?
- Which monitor reads a Child's pain best during surgery?
- Propofol vs. inhaled anesthesia: which one spares your recovery?